Novo Nordisk
Stock
Stock
ISIN: DK0062498333
Ticker: NOVO B
DK0062498333
NOVO B
Price
Price
CHART BY
Historical dividends and forecast
The next dividend will be paid on 01.04.2025
$0.277
CHART BY
Frequently asked questions
What is Novo Nordisk's market capitalization?
The market capitalization of Novo Nordisk is $370.65B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
What is Novo Nordisk's Price-to-Earnings (P/E) ratio?
The Price-to-Earnings (P/E) ratio (TTM) for Novo Nordisk is 26.25. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.
What is the Earnings Per Share (EPS) for Novo Nordisk?
Novo Nordisk's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $3.181. EPS indicates the company's profitability on a per-share basis.
What are the analyst ratings and target price for Novo Nordisk's stock?
Currently, 35 analysts cover Novo Nordisk's stock, with a consensus target price of $118.36. Analyst ratings provide insights into the stock's expected performance.
What is Novo Nordisk's revenue over the trailing twelve months?
Over the trailing twelve months, Novo Nordisk reported a revenue of $40.73B.
Is Novo Nordisk paying dividends?
Yes, Novo Nordisk is paying dividends. The next payment is scheduled for 01.04.2025, with an expected amount of .
What is the EBITDA for Novo Nordisk?
Novo Nordisk's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $20.98B. EBITDA measures the company's overall financial performance.
What is the free cash flow of Novo Nordisk?
Novo Nordisk has a free cash flow of $10.35B. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
How many employees does Novo Nordisk have, and what sector and industry does it belong to?
Novo Nordisk employs approximately 76,302 people. It operates in the Health Care sector, specifically within the Major Pharmaceuticals industry.
What is the free float of Novo Nordisk's shares?
The free float of Novo Nordisk is 3.15B. Free float refers to the number of shares available for public trading, excluding restricted shares.
Financials
- Market Cap
- $370.65B
- EPS (TTM)
- $3.181
- Free Float
- 3.15B
- P/E ratio (TTM)
- 26.25
- Revenue (TTM)
- $40.73B
- EBITDA (TTM)
- $20.98B
- Free Cashflow (TTM)
- $10.35B
Pricing
- 1D span
- $83.57$88.94
- 52W span
- $73.08$148.39
Analyst Ratings
The price target is $118.36 and the stock is covered by 35 analysts.
Buy
24
Hold
10
Sell
1
Information
Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.
- Employees
- 76,302
- Industries
- Major Pharmaceuticals
- Sector
- Health Care
Identifier
- ISIN
- DK0062498333
- Primary Ticker
- NOVO B
Knockouts
Finance data from FactSet